These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23910707)

  • 1. New insights into the mechanism underlying the synergistic action of ionizing radiation with platinum chemotherapeutic drugs: the role of low-energy electrons.
    Rezaee M; Hunting DJ; Sanche L
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):847-53. PubMed ID: 23910707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytotoxicities of platinum compounds.
    Goodisman J; Hagrman D; Tacka KA; Souid AK
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA radiosensitization by terpyridine-platinum: damage induced by 5 and 10 eV transient anions.
    Ouyang L; Lin H; Zhuang P; Shao Y; Khosravifarsani M; Guérin B; Zheng Y; Sanche L
    Nanoscale; 2023 Feb; 15(7):3230-3242. PubMed ID: 36722902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustered DNA Damages induced by 0.5 to 30 eV Electrons.
    Zheng Y; Sanche L
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of platinum-DNA adduct repair.
    Chaney SG; Vaisman A
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
    Ang WH; Myint M; Lippard SJ
    J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation.
    Zheng Y; Sanche L
    Radiat Res; 2009 Jul; 172(1):114-9. PubMed ID: 19580513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers.
    Fong CW
    Free Radic Biol Med; 2016 Oct; 99():99-109. PubMed ID: 27417937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single subexcitation-energy electron can induce a double-strand break in DNA modified by platinum chemotherapeutic drugs.
    Rezaee M; Alizadeh E; Cloutier P; Hunting DJ; Sanche L
    ChemMedChem; 2014 Jun; 9(6):1145-9. PubMed ID: 24376113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
    Saris CP; van de Vaart PJ; Rietbroek RC; Blommaert FA
    Carcinogenesis; 1996 Dec; 17(12):2763-9. PubMed ID: 9006117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-DSB clustered DNA lesions induced by ionizing radiation are largely responsible for the loss of plasmid DNA functionality in the presence of cisplatin.
    Kouass Sahbani S; Rezaee M; Cloutier P; Sanche L; Hunting DJ
    Chem Biol Interact; 2014 Jun; 217():9-18. PubMed ID: 24732435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral platinum analogue JM216, a radiosensitizer in oxic murine cells.
    van de Vaart PJ; Klaren HM; Hofland I; Begg AC
    Int J Radiat Biol; 1997 Dec; 72(6):675-83. PubMed ID: 9416790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
    Mandal R; Kalke R; Li XF
    Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
    Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
    Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of X-ray-induced breaks in DNA bound to molecules containing platinum: a possible application to hadrontherapy.
    Kobayashi K; Frohlich H; Usami N; Takakura K; Le Sech C
    Radiat Res; 2002 Jan; 157(1):32-7. PubMed ID: 11754639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
    J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S; Bolanowska-Higdon W; Zdanowicz J; Hitt S; Pendyala L
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):398-406. PubMed ID: 11761458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-induced damage of cellular DNA.
    Woynarowski JM; Faivre S; Herzig MC; Arnett B; Chapman WG; Trevino AV; Raymond E; Chaney SG; Vaisman A; Varchenko M; Juniewicz PE
    Mol Pharmacol; 2000 Nov; 58(5):920-7. PubMed ID: 11040038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum anti-cancer drugs: Free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect.
    Fong CW
    Free Radic Biol Med; 2016 Jun; 95():216-29. PubMed ID: 27012421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.